Dare Bioscience (DARE) Cash from Financing Activities (2013 - 2025)
Dare Bioscience (DARE) recorded Cash from Financing Activities of $424,129 in Q4 2025, compared with -$211,320 a year earlier and down 97.7% from the prior quarter.
Powered by 
Analysis
Dare Bioscience (DARE) Cash from Financing Activities (2013 - 2025) Analysis & Trends
For FY2025, Dare Bioscience reported Cash from Financing Activities of $19.28 million.
- Annual Cash from Financing Activities has a five-year compound annual growth rate of -5.2% (FY2020 to FY2025).
- Across earlier years, Cash from Financing Activities came in at $354,522 in FY2024 (-97.7%), $15.64 million in FY2023, $1.34 million in FY2022 (-98.2%) and $75.85 million in FY2021 (+201.8%).
- Quarterly Cash from Financing Activities has ranged from -$211,320 in Q4 2024 to $35.22 million in Q3 2021 over the past five years.
- Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 552.3% in Q3 2021, against a decline of 100.0% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $18.65 million (Q3 2025), -$43,794 (Q2 2025) and $246,577 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Dare Bioscience | 12.89 Mn | -52.57 Mn | -132,343.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 424,129.00 |
| Sep 30, 2025 | 18.65 Mn |
| Jun 30, 2025 | -43,794.00 |
| Mar 31, 2025 | 246,577.00 |
| Dec 31, 2024 | -211,320.00 |
| Sep 30, 2024 | 436,444.00 |
| Jun 30, 2024 | 115,366.00 |
| Mar 31, 2024 | 14,032.00 |
| Dec 31, 2023 | 5.31 Mn |
| Sep 30, 2023 | 8.58 Mn |
| Jun 30, 2023 | 452,195.00 |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | -1.00 |
| Sep 30, 2022 | 4,456.00 |
| Jun 30, 2022 | 1.34 Mn |
| Dec 31, 2021 | 16.00 Mn |
| Sep 30, 2021 | 35.22 Mn |
| Jun 30, 2021 | 13.25 Mn |
| Mar 31, 2021 | 11.37 Mn |
| Dec 31, 2020 | 8.45 Mn |
API Access
Dare Bioscience Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=DARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "DARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=DARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();